ABVX - Total Utang marang Modal Abivax SA

Logo perusahaan publik Abivax S.A. (ABVX)

The ABIVAX (ABVX) price chart demonstrates a debt-to-equity ratio of 0.00. The business relies on AI simulations for immunity analysis and test automation, which accelerates drug releases. Proven biomaterial delivery channels ensure development stability. Meanwhile, the biotechnology company's operations strictly comply with environmental standards regarding waste recycling and equipment energy efficiency.

ABVX: Total Utang marang Modal ABIVAX 21.02.2024 - 30.10.2026

Rincian analitis perusahaan ABIVAX

- rega lan prakiraan konsensus rega:
Bagan rega abivax.com|ABVX - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Abivax|ABVX - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Abivax|ABVX - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku abivax.com|ABVX - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas ABIVAX|ABVX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Abivax S.A.|ABVX - Gunggung utang perusahaan|Utang marang nilai buku Abivax|ABVX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Abivax|Likuiditas cepet abivax.com
- informasi bathi lan kelipatan valuasi:
ABVX - Penghasilan resik
Analisis dhasar perusahaan:Abivax Corp
Barang utama Abivax SA

The debt-to-equity ratio determines the proportion of borrowed funds within the asset structure relative to equity, allowing for an assessment of financial stability and the degree of business dependence on creditors. By analyzing the debt-to-equity trend, investors determine the ability of ABIVAX (ABVX) to fund the development of immunomodulatory drugs for the treatment of colitis without risking insolvency while scaling its innovative ecosystem.

Analisis pesaing ABIVAX

Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ADMA|PTGX (Protagonist Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal IMVT (Immunovant, Inc.)|Total Utang marang Modal kiniksa.com KNSA|GRFS - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ADPT (Adaptive Biotech)|Celldex (CLDX) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Aurinia Corp|BCRX (BioCryst) - Total Utang marang Modal|Total Utang marang Modal veratx.com|Rasio Total Utang marang Ekuitas DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ABCL (abcellera.com)|Koefisien Total Utang marang Modal Tourmaline (TRML)|PGEN - Utang marang Ekuitas|pharming.com (PHAR) - Rasio Total Utang marang Ekuitas|Nektar Therapeutics Inc. (NKTR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Upstream Bio, Inc.|Rasio Total Utang marang Ekuitas ZBIO|Total Utang marang Modal Immunome Bio|Utang marang Ekuitas Gossamer Bio, Inc. (GOSS)|kalvista.com - Rasio Utang marang Ekuitas|Total Utang marang Modal SEPN (Septerna)|Pieris Pharma (PVLA) - Utang marang Modal|Savara Corp - Total Utang marang Modal|RIGL - Total Utang marang Modal|ANAB: Total Utang marang Modal|ATXS (astriatx.com) - Utang marang Ekuitas|ENGN (enGene) - Total Utang marang Modal|RAPT Therapeutics Inc. (RAPT) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas JBIO (Aerovate Therapeutics Inc)|Utang marang Ekuitas ACRS (Aclaris Therapeutics, Inc)|Total Utang marang Modal KYTX (Kyverna Therapeutics)|Total Utang marang Modal tizianalifesciences.com TLSA|CABA: Rasio Total Utang marang Ekuitas|VTYX (Ventyx Biosciences Inc.) - Rasio Utang marang Ekuitas|THTX: Total Utang marang Modal|Avalo Therapeutics Inc (AVTX) - Total Utang marang Modal|ELDN (Eledon Pharmaceuticals) - Total Utang marang Modal|Utang marang Ekuitas AGEN|Rasio Total Utang marang Ekuitas CLYM (Climb Bio)|Utang marang Ekuitas ZURA (Zura Bio Ltd)|aTyr - Rasio Total Utang marang Ekuitas|ADAG: Rasio Utang marang Ekuitas|IMA - Utang marang Ekuitas|Utang Agregat marang Ekuitas STTK|EQ: Total Utang marang Modal|Connect Biopharma Holdings Limited - Rasio Kabeh Utang marang Dana Pribadi|IMUX (Immunic Therapeutics) - Total Utang marang Modal|Total Utang marang Modal Atara Biotherapeutics Inc|Utang marang Ekuitas InflaRx N.V. (IFRX)|XFOR (x4pharma.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Adicet Bio, Inc. ACET|CELU - Rasio Total Utang marang Ekuitas|INmune Bio Corp - Total Utang marang Modal|BRNS - Total Utang marang Modal|KZR (Kezar Life Sciences) - Rasio Total Utang marang Ekuitas|sabbiotherapeutics.com - Rasio Kabeh Utang marang Dana Pribadi|AKTX (Akari Therapeutics Plc) - Total Utang marang Modal|Enlivex Therapeutics, Ltd. (ENLV) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Q32 Bio Inc. (QTTB)|Rasio Total Utang marang Ekuitas GeoVax Corp GOVX|Utang marang Ekuitas Edesa Biotech, Inc. EDSA|IBIO - Rasio Total Utang marang Ekuitas|CARM: Rasio Total Utang marang Ekuitas|XTLB - Total Utang marang Modal|boltbio.com (BOLT) - Utang marang Ekuitas|Rasio Utang marang Ekuitas HCWB|APVO (Aptevo Therapeutics, Inc.) - Total Utang marang Modal|Utang marang Modal AIM ImmunoTech, Inc. AIM|Total Utang marang Modal ADTX|Total Utang marang Modal GRI Bio Inc (GRI)|Total Utang marang Modal XRTX (XORTX)|Vyome Therapeutics - Utang marang Ekuitas|Revelation Biosciences - Total Utang marang Modal|Koefisien Total Utang marang Modal indaptusrx.com INDP|SCNI (Scinai Immunotherapeutics Ltd.) - Rasio Total Utang marang Ekuitas|CALI (CalciMedica) - Utang marang Ekuitas|AFMD (Affimed NV) - Total Utang marang Modal|Total Utang marang Modal Allakos Therapeutics|Rasio Total Utang marang Ekuitas HOOK (HOOKIPA Pharma Inc.)|igmbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal ITOS (iTeos Therapeutics, Inc.)|Total Utang marang Modal Ocean Biomedical Inc OCEA|TC BioPharm (Holdings) PLC - Total Utang marang Modal|THRD: Utang marang Ekuitas